Zai Lab (ZLAB) Debt Ratio (2018 - 2026)
Zai Lab (ZLAB) reported Debt Ratio of 0.2 for Q1 2026, up 32.04% on a YoY basis from 0.15 in Q1 2025, and up 11.85% sequentially from 0.17 in Q4 2025.
Zai Lab (ZLAB) Debt Ratio (2018 - 2026) Analysis & Trends
Zai Lab (ZLAB) has 5 years of Debt Ratio data on file, last reported at 0.2 in Q1 2026.
- For the quarter ending Q1 2026, Debt Ratio rose 32.04% year-over-year to 0.2; the trailing twelve-month figure through Mar 2026 stood at 0.2 (up 32.04% YoY), and the FY2025 full-year result was 0.17, up 57.06% from the prior year.
- Debt Ratio improved to 0.2 in Q1 2026, from 0.17 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.2 in Q1 2026 to a low of 0.05 in Q1 2024.
- A 3-year average of 0.13 and a median of 0.15 in 2025 frame the typical range for Debt Ratio.
- Across the five-year window, Debt Ratio soared 202.61% in 2025 and jumped 32.04% in 2026, its largest moves.
- Tracing ZLAB's Debt Ratio over 3 years: stood at 0.11 in 2024, then soared by 57.06% to 0.17 in 2025, then rose by 11.85% to 0.2 in 2026.
- Business Quant data shows ZLAB's Debt Ratio at 0.2 in Q1 2026, 0.17 in Q4 2025, and 0.18 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 1.41 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.11 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.05 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Zai Lab | 21.37 Bn | 21.37 Bn | -34.26 Mn | 0.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.20 |
| Dec 31, 2025 | 0.17 |
| Sep 30, 2025 | 0.18 |
| Jun 30, 2025 | 0.15 |
| Mar 31, 2025 | 0.15 |
| Dec 31, 2024 | 0.11 |
| Sep 30, 2024 | 0.11 |
| Jun 30, 2024 | 0.07 |
| Mar 31, 2024 | 0.05 |
| Dec 31, 2019 | 0.02 |
| Dec 31, 2018 | 0.01 |